Results 141 to 150 of about 114,932 (339)

A bench experiment to investigate the time available to replace a near‐depleted E‐size nitrous oxide cylinder when using a ‘mobile manifold’ supply system

Anaesthesia, EarlyView.
Scarlett Tankard, Cliff Shelton
wiley   +1 more source

Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and sodium–glucose cotransporter 2 (SGLT2) inhibitors are widely used for the treatment of type 2 diabetes, yet their downstream consequences in routine clinical practice remain incompletely characterized.
Yazan Alhamdan, Jason C. Hsu, Christine Y. Lu   +2 more
wiley   +1 more source

HYPNOSIS FOR IMPROVEMENT OF PHYSICAL STRENGTH AND RESISTANCE

Publicaciones, 2014
In this case study we assessed the effectiveness of hypnosis for the physical force in sportsmen. Participant was 1 amateur cyclist with hypnotic suggestion.
Félix Zurita Ortega, Rubén Fernández García, Antonio José Pérez Cortés, Manuel Castro Sánchez   +3 more
doaj  

Effects of hypnotic drugs on performance before and after sleep [PDF]

The effects of various hypnotics on sleep stage parameters and on the parameters of effectiveness were evaluated along with the effects of several commonly used yet distinctly different hypnotics on daytime performance. The effects on daytime performance
Bixler, E. O., Kales, A., Kales, J. D.
core   +1 more source

Hypnotism [PDF]

Proceedings of the Royal Society of Medicine, 1908
openaire   +2 more sources

Hypnotic Medications and Suicide: Risk, Mechanisms, Mitigation, and the FDA.

American Journal of Psychiatry, 2017
W. McCall, R. Benca, P. Rosenquist, Mary Anne Riley, L. Mccloud, Jill C. Newman, Doug Case, M. Rumble, A. Krystal   +8 more
semanticscholar   +1 more source

Use of Glucagon‐Like Peptide‐1 Receptor Agonists and Risk of Parkinson's Disease: Scandinavian Cohort Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To investigate the association between use of GLP‐1 receptor agonists and incident Parkinson's disease. Material and Methods Cohort study using data from nationwide registers in Denmark, Norway and Sweden and an active‐comparator, new‐user design.
Arvid Engström, Henrik Svanström, Anders Hviid, Björn Eliasson, Soffia Gudbjörnsdottir, Viktor Wintzell, Kristian Hveem, Christian Jonasson, Mads Melbye, Peter Ueda, Björn Pasternak   +10 more
wiley   +1 more source

How Undergraduate Students Perceive Postgraduate Training and Continuing Education: A French Survey

European Journal of Dental Education, EarlyView.
ABSTRACT Introduction The practice of Continuing Dental Education (CDE) serves as a fundamental requirement for lifelong learning but there is limited knowledge about how dental students handle CDE during their final educational period. This study examined how final‐year French dental students perceive CDE through their expectations, motivation and ...
Margot Queney, Catherine Petit, Pierre‐Yves Gegout, Olivier Huck   +3 more
wiley   +1 more source

National Trends in Antidepressant, Benzodiazepine, and Other Sedative-Hypnotic Treatment of Older Adults in Psychiatric and Primary Care.

Journal of Clinical Psychiatry, 2017
D. Maust, F. Blow, I. Wiechers, H. Kales, S. Marcus   +4 more
semanticscholar   +1 more source

Analgesic effects of alpha‐2‐adrenoreceptor agonists in equine medicine: systemic, spinal, and local applications

Equine Veterinary Education, EarlyView.
Summary Alpha‐2‐adrenoreceptor agonists provide analgesia when used as sole agents but can also be used in combination with other drugs for their additive and potentially synergistic effects. Further, because of their effects on blood flow, alpha‐2‐adrenoreceptor agonists act to extend and perhaps intensify the effects of drugs, such as local ...
J. Brandly, J. R. Page, J. A. E. Hubbell, W. W. Muir III, K. Hopster   +4 more
wiley   +1 more source